Chapter 6 – Prostaglandins and Other Lipid Mediators in Reproductive Medicine

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/B978-1-4160-4907-4.00006-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipidomic analysis reveals prostanoid profiles in human term pregnant myometrium.

  2010cited by this paper
• Insulin/FOXO signaling regulates ovarian prostaglandins critical for reproduction.

  2010cited by this paper
• Mammalian oocytes are targets for prostaglandin E2 (PGE2) action

  2010cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature

  2010cited by this paper
• Arachidonic acid cytochrome P450 epoxygenase pathway Work from my laboratory cited in this review was supported by National Institutes of Health grants HL049264 and HL072845. Published, JLR Papers in Press, October 23, 2008.

  2009cited by this paper
• Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle.

  2009cited by this paper
• What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases.

  2008cited by this paper
• Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.

  2008cited by this paper
• Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition.

  2008cited by this paper
• Prostaglandins in labor--a translational approach.

  2008cited by this paper
• Possible dual roles for prostacyclin in human pregnancy and labor.

  2008cited by this paper
• Age-Dependent Loss of Sperm Production in Mice via Impaired Lysophosphatidic Acid Signaling1

  2008cited by this paper
• Expression and regulation of prostaglandin E synthase isoforms in human myometrium with labour.

  2007cited by this paper
• Prostacyclin receptor signaling and early embryo development in the mouse.

  2007cited by this paper
• ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Intracavernous Injections of Prostaglandin E1 for Erectile Dysfunction: Patient Satisfaction and Quality of Sex Life on Long-Term Treatment

  2007cited by this paper
• Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour.

  2007cited by this paper
• Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activated receptor delta activation: implication in IVF.

  2007cited by this paper
• Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target

  2007cited by this paper
• Targeted Cyclooxygenase Gene (Ptgs) Exchange Reveals Discriminant Isoform Functionality*

  2007cited by this paper
• Prostaglandins and the initiation of blastocyst implantation and decidualization.

  2007cited by this paper
• Mechanisms of disease: Leukotrienes

  2007cited by this paper
• Lipoxins and new lipid mediators in the resolution of inflammation.

  2006cited by this paper
• Sphingosine-1-Phosphate Receptor Expression and Signaling Correlate with Uterine Prostaglandin-Endoperoxide Synthase 2 Expression and Angiogenesis During Early Pregnancy1

  2006cited by this paper
• The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor

  2006cited by this paper
• Lysophosphatidic receptor, LPA3, is positively and negatively regulated by progesterone and estrogen in the mouse uterus.

  2006cited by this paper
• Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus.

  2006cited by this paper
• GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5*

  2006cited by this paper
• Transport of glutathione and glutathione conjugates by MRP1.

  2006cited by this paper
• Eicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue Responses

  2006cited by this paper
• Expression and Contribution of Three Different Isoforms of Prostaglandin E Synthase in the Bovine Endometrium1

  2005cited by this paper
• Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition.

  2005cited by this paper
• A central role for ceramide in the age‐related acceleration of apoptosis in the female germline

  2005cited by this paper
• LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing

  2005cited by this paper
• Effects of Acid Sphingomyelinase Deficiency on Male Germ Cell Development and Programmed Cell Death1

  2005cited by this paper
• Structural and functional characteristics of S1P receptors

  2004cited by this paper
• Mechanisms of lysophosphatidic acid production.

  2004cited by this paper
• Loss of Cyclooxygenase-2 Retards Decidual Growth but Does Not Inhibit Embryo Implantation or Development to Term

  2003cited by this paper
• The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs

  2003cited by this paper
• Administration Time–Dependent Influence of Aspirin on Blood Pressure in Pregnant Women

  2003cited by this paper
• Sphingosine-1-phosphate in inhibition of male germ cell apoptosis in the human testis.

  2003cited by this paper
• Mouse Placental Prostaglandins Are Associated with Uterine Activation and the Timing of Birth1

  2003cited by this paper
• Valdecoxib, a Cyclooxygenase‐2‐Specific Inhibitor, Is Effective in Treating Primary Dysmenorrhea

  2002cited by this paper
• Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.

  2002cited by this paper
• Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus

  2002cited by this paper
• Misoprostol in second and early third trimester for termination of pregnancies with fetal anomalies

  2002cited by this paper
• Cytosolic phospholipase A2α deficiency is crucial for 'on-time' embryo implantation that directs subsequent development

  2002cited by this paper
• Selective Interleukin-12 Synthesis Defect in 12/15-Lipoxygenase-deficient Macrophages Associated with Reduced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia*

  2002cited by this paper
• A novel pathway of prostacyclin signaling-hanging out with nuclear receptors.

  2002cited by this paper
• Cyclooxygenase-2 Regulates Apoptosis in Rat Epididymis Through Prostaglandin D21

  2002cited by this paper
• Cyclooxygenase 2 Pathway Mediates IL-1β Regulation of IL-1α, -1β, and IL-6 mRNA Levels in Leydig Cell Progenitors

  2002cited by this paper
• Ovulation: new dimensions and new regulators of the inflammatory-like response.

  2002cited by this paper
• 15-Deoxy-Δ12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils1

  2002cited by this paper
• Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys.

  2002cited by this paper
• Immunohistochemical localization of microsomal PGE synthase-1 and cyclooxygenases in male mouse reproductive organs.

  2002cited by this paper
• Early pregnancy termination with vaginal misoprostol before and after 42 days gestation.

  2002cited by this paper
• Lysophosphatidic Acid and Its Role in Reproduction

  2002cited by this paper
• Developmental expression of functional cyclooxygenases in zebrafish

  2002cited by this paper
• A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy

  2002cited by this paper
• Coordinate regulation of prostaglandin metabolism for induction of parturition in mice.

  2002cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and Reversible Female Infertility

  2002cited by this paper
• A prospective randomized safety trial of celecoxib for treatment of preterm labor.

  2002cited by this paper
• Platelet activation in obese women: role of inflammation and oxidant stress.

  2002cited by this paper
• Preinduction Cervical Ripening: Basis and Methods of Current Practice

  2002cited by this paper
• COX-2 Inhibitors and Their Role in Gynecology

  2002cited by this paper
• Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study.

  2001cited by this paper
• Genetic and pharmacological analysis of prostanoid receptor function.

  2001cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.

  2001cited by this paper
• Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2

  2001cited by this paper
• Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2.

  2001cited by this paper
• Prostacyclin-dependent Apoptosis Mediated by PPARδ*

  2001cited by this paper
• Series Introduction: COX in a crystal ball: current status and future promise of prostaglandin research

  2001cited by this paper
• Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer

  2001cited by this paper
• Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

  2001cited by this paper
• Commuting the death sentence: how oocytes strive to survive

  2001cited by this paper
• Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.

  2001cited by this paper
• Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.

  2001cited by this paper
• The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle.

  2001cited by this paper
• Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E—Deficient Mice

  2001cited by this paper
• Abnormal uterus with polycysts, accumulation of uterine prostaglandins, and reduced fertility in mice heterozygous for acyl-CoA synthetase 4 deficiency.

  2001cited by this paper
• Prevention of pre-eclampsia: status and perspectives 2000.

  2001cited by this paper
• Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension

  2001cited by this paper
• Arachidonic acid as a bioactive molecule.

  2001cited by this paper
• Diversification of Cyclooxygenase-2-Derived Prostaglandins in Ovulation and Implantation1

  2001cited by this paper
• The isoprostanes in biology and medicine.

  2001cited by this paper
• The N-terminal “β-Barrel” Domain of 5-Lipoxygenase Is Essential for Nuclear Membrane Translocation*

  2001cited by this paper
• Lysophospholipids--Receptor Revelations

  2001cited by this paper
• Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

  2001cited by this paper
• Why there are two cyclooxygenase isozymes.

  2001cited by this paper
• Regulated formation of eicosanoids.

  2001cited by this paper
• The coxibs, selective inhibitors of cyclooxygenase-2.

  2001cited by this paper
• Prostaglandin inhibitors as tocolytic agents.

  2001cited by this paper
• Indomethacin for Preterm Labor: A Randomized Comparison of Vaginal and Rectal‐Oral Routes

  2000cited by this paper
• Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation

  2000cited by this paper
• The expanding superfamily of phospholipase A(2) enzymes: classification and characterization.

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Does prostaglandin E1 therapy modify the intracavernous musculature?

  2000cited by this paper
• Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo.

  2000cited by this paper
• Characterization of the Human Cysteinyl Leukotriene 2 Receptor*

  2000cited by this paper
• Distribution and function of prostanoid receptors: studies from knockout mice.

  2000cited by this paper

• Genome-wide scans identify biological and metabolic pathways regulating carcass and meat quality traits in beef cattle.

  2023cites this paper
• Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model

  2023cites this paper
• Promotion of the prehierarchical follicle growth by postovulatory follicles involving PGE2–EP2 signaling in chickens

  2018cites this paper
• Direct Mass Spectrometry Differentiation of Ectopic and Eutopic Endometrium in Patients with Endometriosis.

  2017cites this paper
• American Ginseng Regulates Gene Expression to Protect against Premature Ovarian Failure in Rats

  2015cites this paper
• Autotaxin as a novel, tissue‐remodeling‐related factor in regressing corpora lutea of cycling rats

  2013cites this paper
• A comprehensive immunohistochemistry of prostaglandins F2α and E2 synthetic enzymes in rat ovary and uterus around parturition.

  2013cites this paper
• Group IVA phospholipase A2 optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2

  2012cites this paper